Versor Investments LP Invests $787,000 in Oscar Health, Inc. (NYSE:OSCR)

Versor Investments LP acquired a new stake in Oscar Health, Inc. (NYSE:OSCR) in the 3rd quarter, Holdings Channel.com reports. The fund acquired 37,100 shares of the company’s stock, valued at approximately $787,000.

Other large investors have also bought and sold shares of the company. Assenagon Asset Management S.A. increased its position in shares of Oscar Health by 32.9% during the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock worth $32,368,000 after acquiring an additional 507,009 shares in the last quarter. FCG Investment Co acquired a new stake in shares of Oscar Health in the 3rd quarter valued at about $986,000. Jupiter Asset Management Ltd. acquired a new stake in shares of Oscar Health in the 1st quarter valued at about $653,000. Toth Financial Advisory Corp lifted its holdings in shares of Oscar Health by 73,185.7% in the third quarter. Toth Financial Advisory Corp now owns 51,300 shares of the company’s stock valued at $1,088,000 after purchasing an additional 51,230 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of Oscar Health by 153.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after buying an additional 2,409,160 shares during the period. 75.70% of the stock is owned by institutional investors.

Insider Activity at Oscar Health

In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the sale, the executive vice president now directly owns 392,607 shares in the company, valued at $6,697,875.42. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of the company’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $17.06, for a total transaction of $286,488.58. Following the completion of the sale, the executive vice president now directly owns 392,607 shares in the company, valued at $6,697,875.42. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the transaction, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 169,569 shares of company stock valued at $3,007,069 over the last quarter. 25.11% of the stock is owned by corporate insiders.

Oscar Health Stock Performance

Shares of NYSE:OSCR opened at $13.56 on Wednesday. Oscar Health, Inc. has a 12-month low of $6.80 and a 12-month high of $23.79. The company’s 50 day moving average price is $18.45 and its two-hundred day moving average price is $18.36. The firm has a market cap of $3.28 billion, a PE ratio of -228.00, a PEG ratio of 31.17 and a beta of 1.67. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The company had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a return on equity of 2.91% and a net margin of 0.35%. Oscar Health’s revenue was up 68.3% on a year-over-year basis. During the same quarter last year, the business earned ($0.29) EPS. Equities research analysts predict that Oscar Health, Inc. will post 0.02 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. UBS Group assumed coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price on the stock. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a research note on Tuesday, September 10th. One research analyst has rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $22.93.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.